The estimated net worth of Samuel Bates Martin is at least $996K dollars as of June 9, 2025. Samuel Bates Martin is the SVP AND CFO of Celldex Therapeutics, Inc. and owns shares of Celldex Therapeutics, Inc. (CLDX) stock worth about $996K.
Signature
/s/ Anthony S. Marucci, attorney-in-fact for Samuel Bates Martin
Insider Transactions Reported by Samuel Bates Martin:
Sym
Company
Class
Transaction
%
Value $
* Price $
Shares
Shares After
Date
Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.